Assignee
PORTON PHARMA SOLUTIONS LTD
CN·2 granted patents·2 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
4 records- 0161US2024141306A1Imine reductase mutant, co-expressed recombinant enzyme of imine reductase and glucose dehydrogenase, and applications thereofPORTON PHARMA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 0257US12319947B2Method for preparing (S)-nicotine by reductionPORTON PHARMA SOLUTIONS LTD·Filed 2023·Granted Jun 3, 2025·0 cites·10 claims
- 0356US11459291B2Method of preparation of (1R,3S)-3-amino-1-cyclopentanol and salt thereofPORTON PHARMA SOLUTIONS LTD·Filed 2021·Granted Oct 4, 2022·0 cites·4 claims
- 0455US2026085072A1Method for preparing intermediate of adrenergic receptor agonistPORTON PHARMA SOLUTIONS LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PORTON PHARMA SOLUTIONS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →